| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/02/2009 | EP2128272A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 12/02/2009 | EP2128270A1 Osteoarthritis biomarkers and uses thereof |
| 12/02/2009 | EP2128266A1 Method for detection of compound interacting with molecule located on cell membrane |
| 12/02/2009 | EP2128259A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 12/02/2009 | EP2128257A2 Mutation of the parkin gene, compositions, methods and uses |
| 12/02/2009 | EP2128249A1 Zinc oxide-binding antibody and use thereof |
| 12/02/2009 | EP2128175A1 Interleukin-10 antibodies |
| 12/02/2009 | EP2128173A1 Therapeutic compound for preventing and fighting bone metastases |
| 12/02/2009 | EP2127679A1 SlpA as a tool for recombinant protein and enzyme technology |
| 12/02/2009 | EP2127678A1 SlpA as a tool for recombinant protein and enzyme technology |
| 12/02/2009 | EP2127664A1 Change of the load state of MHC molecules by dipeptides |
| 12/02/2009 | EP2126589A2 Metabolic markers of diabetic conditions and methods of use thereof |
| 12/02/2009 | EP2126588A1 Formation of lipid bilayers |
| 12/02/2009 | EP2126587A1 Device and method for measuring ldl-associated cholesterol |
| 12/02/2009 | EP2126586A1 Direct determination of vitamin d in serum or plasma |
| 12/02/2009 | EP2126585A1 Methods and compositions for modulating il-17f/il-17a biological activity |
| 12/02/2009 | EP2126584A1 Direct mass spectrometric analysis of drug candidates targeting protein complexes |
| 12/02/2009 | EP2126583A1 Diagnosis of collagen ix destruction |
| 12/02/2009 | EP2126582A2 Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis |
| 12/02/2009 | EP2126581A2 Assays using surface-enhanced raman spectroscopy (sers)-active particles |
| 12/02/2009 | EP2126580A2 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| 12/02/2009 | EP2126579A2 Multiplex detection of tumour cells using a panel of agents binding to extracellular markers |
| 12/02/2009 | EP2126578A2 Autoantibodies for protein antigens as markers for cancer of gingivo-buccal complex |
| 12/02/2009 | EP2126576A1 Reagent for detection of analyte and processes thereof |
| 12/02/2009 | EP2126575A2 Methods and targets for identifying compounds for regulating rhinovirus infection |
| 12/02/2009 | EP2126573A2 Diagnostic detection device |
| 12/02/2009 | EP2126572A1 Chromatographic test strips for one or more analytes |
| 12/02/2009 | EP2126570A1 A method for sensing a chemical |
| 12/02/2009 | EP2126569A2 Indirect lateral flow sandwich assay |
| 12/02/2009 | EP2126567A2 Improved antibody profiling sensitivity through increased reporter antibody layering |
| 12/02/2009 | EP2126566A2 Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors |
| 12/02/2009 | EP2126565A1 Method for the assessment of the inhibitory activity of antibodies against insulin-like growth factor i receptor |
| 12/02/2009 | EP2126564A1 Method of diagnosis |
| 12/02/2009 | EP2126563A1 Method for determining health status by analyzing analytes |
| 12/02/2009 | EP2126562A2 Clinical intervention directed diagnostic methods |
| 12/02/2009 | EP2126560A1 Simulation cache to expedite complex modeling and simulation processes |
| 12/02/2009 | EP2126555A2 System and method for operating an electrochemical analyte sensor |
| 12/02/2009 | EP2126551A1 Analysis of functional fluids |
| 12/02/2009 | EP2126548A2 Ansamycin formulations and methods of use thereof |
| 12/02/2009 | EP2126547A1 Pressurized crystallization point automated test apparatus |
| 12/02/2009 | EP2126136A2 Diagnosis of prostate cancer |
| 12/02/2009 | EP2126117A2 Gene polymorphisms predictive for dual tki therapy |
| 12/02/2009 | EP2126111A1 Method, device and kit for determining conditions related to a dysfunction of the renal proximal tubule |
| 12/02/2009 | EP2126109A2 Biomarkers of sirtuin activity and methods of use thereof |
| 12/02/2009 | EP2126108A1 Detection system apparatus |
| 12/02/2009 | EP2126055A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3. |
| 12/02/2009 | EP2126053A2 Apocrine cell line |
| 12/02/2009 | EP2126039A2 Microfluidic devices and methods of generating and using same |
| 12/02/2009 | EP2125992A1 Fluorescent organic nanocrystals for producing biosensors |
| 12/02/2009 | EP2125911A2 Surface-bound fluorinated esters for amine capture |
| 12/02/2009 | EP2125899A1 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function |
| 12/02/2009 | EP2125890A2 Antibodies to phosphorylated-irak4 |
| 12/02/2009 | EP2125888A1 Method of providing human tumor-specific antibodies |
| 12/02/2009 | EP2125659A2 Silica magnetic particles with a high nucleic acid binding capability |
| 12/02/2009 | EP2125605A1 Sample handling device |
| 12/02/2009 | EP2125356A1 Paper converting roll with an elastomeric roll cover |
| 12/02/2009 | EP2125222A1 Analyte sensors and methods of use |
| 12/02/2009 | EP2125215A1 Particle facilitated testing |
| 12/02/2009 | EP2125037A2 Methods and compositions for treating il-4 or il-13 related fibrosis related pathologies |
| 12/02/2009 | EP2125036A1 Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients |
| 12/02/2009 | EP2125034A2 Methods and materials for identifying the origin of a carcinoma of unknown primary origin |
| 12/02/2009 | EP2125033A2 Compositions and methods relating to organ-, tissue-, and cell-specific antibodies |
| 12/02/2009 | EP2124998A2 Compositions and methods for treating inflammation and auto-immune diseases |
| 12/02/2009 | EP2124989A2 Methods of treating infection |
| 12/02/2009 | EP2124955A2 Inhibition of pde2a |
| 12/02/2009 | EP2124880A2 Fluorescent nanoparticles |
| 12/02/2009 | EP2124749A1 Noninvasive method to estimate variation of blood glucose levels using metabolic measurements |
| 12/02/2009 | EP2124720A2 Device and method for automatic data acquisition and/or detection |
| 12/02/2009 | EP1732951B1 Monoclonal antibodies with specificity for fetal erythroid cells |
| 12/02/2009 | EP1581249B1 G-csf for use in the treatment of amyotrophic lateral sclerosis |
| 12/02/2009 | EP1555324B1 Defructosylation method |
| 12/02/2009 | EP1461821B1 Method for measuring adsorbed and interstitial fluids |
| 12/02/2009 | EP1432989B1 Randomly ordered arrays and methods of making and using |
| 12/02/2009 | CN201355361Y Control system of full automatic chemiluminescence immunoassay instrument |
| 12/02/2009 | CN201355358Y Heating structure for fuel cell of measuring instrument for measuring alcohol content in expired gas |
| 12/02/2009 | CN201355357Y Biochemical sensing test piece, biochemical sensing system and measuring device |
| 12/02/2009 | CN201355356Y UV solidification lamp box lens hood for solidification seam gum shrinkage ratio testing |
| 12/02/2009 | CN201355355Y Simple cleanness check test device |
| 12/02/2009 | CN201355354Y Pipeline system for measuring pH value of slurry of desulfuration absorption tower |
| 12/02/2009 | CN201355321Y Highly-effective sample digester |
| 12/02/2009 | CN101595388A Multiple analyte immunoassay |
| 12/02/2009 | CN101595387A Continuously repeatable method of detecting antigens in test volume |
| 12/02/2009 | CN101595229A Method and apparatus for enhanced bacteriophage-based diagnostic assays by selective inhibition of potential cross-reactive organisms |
| 12/02/2009 | CN101595132A Use of thermostable biotin-binding protein and solid support having the protein bound thereto |
| 12/02/2009 | CN101595130A Compositions and methods for the diagnosis and treatment of tumor |
| 12/02/2009 | CN101594883A Diagnosis and treatment of cancer using anti-EREG antibody |
| 12/02/2009 | CN101594880A Novel method for treating H.pylori infections |
| 12/02/2009 | CN101594823A Noninvasive method to estimate variation of blood glucose levels using metabolic measurements |
| 12/02/2009 | CN101593403A Alarm system used for gas and/or combustion product |
| 12/02/2009 | CN101592668A Method for quantitatively measuring content of estradiol in extracts of Chinese medicine herbs |
| 12/02/2009 | CN101592667A Glycosylated hemoglobin detection kit and application thereof |
| 12/02/2009 | CN101592666A United test card for homocysteine-folic acid Immune colloidal gold by chromatography and preparation method thereof |
| 12/02/2009 | CN101592665A Leptospira IgM antibody quick detection test strip |
| 12/02/2009 | CN101592664A Hepatitis B e antibody magnetic particle chemiluminescent immunoassay kit and preparation method thereof |
| 12/02/2009 | CN101592663A Hepatitis B e antigen magnetic particle chemiluminescent immunoassay kit and preparation method thereof |
| 12/02/2009 | CN101592662A Hepatitis B surface antibody magnetic particle chemiluminescent immunoassay kit and preparation method thereof |
| 12/02/2009 | CN101592661A Brucellosis antibody competitive enzyme-linked immunosorbent assay reagent kit |
| 12/02/2009 | CN101592660A Brucellosis indirect enzyme-linked immunosorbent assay milk liquid antibody reagent kit |
| 12/02/2009 | CN101592659A System and method for quantitative detection of test strips on basis of continuous fluorescent-substance markers |
| 12/02/2009 | CN101592658A Salbutamol ELISA diagnostic kit and application thereof |